Literature DB >> 26939637

Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.

K Sato1, M Yamada2, H Kuroda2, D Yamamoto2, Y Asano3, Y Inoue3, K Fujii2, T Kumabe2.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral hyperperfusion syndrome is a potential complication of superficial temporal artery-MCA anastomosis for Moyamoya disease. In this study, we evaluated whether TOF-MRA could assess cerebral hyperperfusion syndrome after superficial temporal artery-MCA anastomosis for this disease.
MATERIALS AND METHODS: This retrospective study included patients with Moyamoya disease who underwent superficial temporal artery-MCA single anastomosis. TOF-MRA and SPECT were performed before and 1-6 days after anastomosis. Bilateral ROIs on the source image of TOF-MRA were manually placed directly on the parietal branch of the superficial temporal artery just after branching the frontal branch of the superficial temporal artery and on the contralateral superficial temporal artery on the same axial image, respectively. The change ratio of the maximum signal intensity of the superficial temporal artery on TOF-MRA was calculated by using the following formula: (Postoperative Ipsilateral/Postoperative Contralateral)/(Preoperative Ipsilateral/Preoperative Contralateral).
RESULTS: Of 23 patients (26 sides) who underwent the operation, 5 sides showed cerebral hyperperfusion syndrome postoperatively. There was a significant difference in the change ratio of signal intensity on TOF-MRA observed between the cerebral hyperperfusion syndrome and non-cerebral hyperperfusion syndrome groups (cerebral hyperperfusion syndrome group: 1.88 ± 0.32; non-cerebral hyperperfusion syndrome group: 1.03 ± 0.20; P = .0009). The minimum ratio value for the cerebral hyperperfusion syndrome group was 1.63, and the maximum ratio value for the non-cerebral hyperperfusion syndrome group was 1.30. Thus, no overlap was observed between the 2 groups for the change ratio of signal intensity on TOF-MRA.
CONCLUSIONS: Diagnosis of cerebral hyperperfusion syndrome is indicated by an increase in the change ratio of signal intensity on TOF-MRA by more than approximately 1.5 times the preoperative levels.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 26939637      PMCID: PMC7960344          DOI: 10.3174/ajnr.A4715

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.

Authors:  Miki Fujimura; Takashi Inoue; Hiroaki Shimizu; Atsushi Saito; Shunji Mugikura; Teiji Tominaga
Journal:  Cerebrovasc Dis       Date:  2012-03-28       Impact factor: 2.762

2.  Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease.

Authors:  Toshiya Sugino; Takeshi Mikami; Kei Miyata; Kengo Suzuki; Kiyohiro Houkin; Nobuhiro Mikuni
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-19       Impact factor: 2.136

3.  Parametric imaging of cerebral vascular reserve. 2. Reproducibility, response to CO2 and correlation with middle cerebral artery velocities.

Authors:  A R Naylor; M V Merrick; J M Slattery; A Notghi; C M Ferrington; J D Miller
Journal:  Eur J Nucl Med       Date:  1991

Review 4.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

5.  Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease.

Authors:  Yasuyuki Kaku; Koji Iihara; Norio Nakajima; Hiroharu Kataoka; Kenji Fukuda; Jun Masuoka; Kazuhito Fukushima; Hidehiro Iida; Nobuo Hashimoto
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-01       Impact factor: 6.200

6.  Intracerebral hemorrhage after carotid endarterectomy.

Authors:  D G Piepgras; M K Morgan; T M Sundt; T Yanagihara; L M Mussman
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

7.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

8.  Interobserver reproducibility of signal intensity ratio on magnetic resonance angiography for hemodynamic impact of intracranial atherosclerosis.

Authors:  Xinyi Leng; Hing Lung Ip; Yannie Soo; Thomas Leung; Liping Liu; Edward Feldmann; Ka Sing Wong; David S Liebeskind
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-09-25       Impact factor: 2.136

9.  Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography.

Authors:  J H Greenberg; M Kushner; M Rango; A Alavi; M Reivich
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

10.  Magnetic resonance angiography signal intensity as a marker of hemodynamic impairment in intracranial arterial stenosis.

Authors:  Xinyi Leng; Ka Sing Wong; Yannie Soo; Thomas Leung; Xinying Zou; Yongjun Wang; Edward Feldmann; Liping Liu; David S Liebeskind
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more
  2 in total

1.  Correlation between high perfusion syndrome and stent restenosis after stent implantation.

Authors:  Yingyi Li; Lingtao Tang; Dong Qi; Chunlei Wang; Suxia Zhang; Pengfei Hu; Yun Wang; Bogang Zhang; Kunxi Zhang
Journal:  Exp Ther Med       Date:  2016-10-18       Impact factor: 2.447

2.  Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy.

Authors:  Shibo Wang; Jing Han; Lei Cheng; Nengpeng Li
Journal:  Exp Ther Med       Date:  2017-07-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.